You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Arti V Virkud1, Eric Tchetgen Tchetgen1, Enrique F Schisterman1
1University of Pennsylvania, Perelman School of Medicine, Department of Biostatistics Epidemiology and Informatics.
Conflicting trial results for 17-alpha-hydroxyprogesterone caproate (17OHP-C) in preventing recurrent preterm birth (PTB) may stem from population differences. Transportability methods did not fully reconcile the differing outcomes between the Meis and PROLONG trials.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: